GITRABIN 200mg powder for solution for infusion ACTAVIS
gemcitabine Indicated for: cancer
L01BC05 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
letter G · page 13
gemcitabine Indicated for: cancer
L01BC05 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
gemcitabine Indicated for: cancer
L01BC05 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
gemcitabine Indicated for: cancer
L01BC05 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
givosiran Indicated for: acute hepatic porphyria
carvedilol Indicated for: hypertension; heart failure
carvedilol Indicated for: hypertension; heart failure
carvedilol Indicated for: hypertension; heart failure
latanoprost Indicated for: glaucoma; ocular hypertension
S01EE01 Sensory organs | Antiglaucoma preparations and miotics | Prostaglandin analogues
latanoprost + timolol Indicated for: glaucoma; ocular hypertension
S01ED51 Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents
omeprazole Indicated for: peptic ulcer; gastroesophageal reflux
glimepiride Indicated for: type 2 diabetes mellitus
glimepiride Indicated for: type 2 diabetes mellitus
glimepiride Indicated for: type 2 diabetes mellitus
glimepiride Indicated for: type 2 diabetes mellitus
glimepiride Indicated for: type 2 diabetes mellitus
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
atorvastatin Indicated for: dyslipidemia